Front Row Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-139
| Closed | -$7.28K | – | 650 |
|
2024
Q2 | $7.28K | Sell |
139
-20
| -13% | -$1.05K | ﹤0.01% | 650 |
|
2024
Q1 | $6.47K | Buy |
+159
| New | +$6.47K | ﹤0.01% | 680 |
|
2023
Q4 | – | Sell |
-134
| Closed | -$5.12K | – | 614 |
|
2023
Q3 | $5.12K | Hold |
134
| – | – | ﹤0.01% | 665 |
|
2023
Q2 | $5K | Hold |
134
| – | – | ﹤0.01% | 665 |
|
2023
Q1 | $5K | Buy |
134
+34
| +34% | +$1.27K | ﹤0.01% | 667 |
|
2022
Q4 | $6K | Buy |
100
+19
| +23% | +$1.14K | ﹤0.01% | 608 |
|
2022
Q3 | $3K | Buy |
+81
| New | +$3K | ﹤0.01% | 751 |
|